Ozone oxidative preconditioning: a protection against cellular damage by free radicals.

Ozone oxidative preconditioning: a protection against cellular damage by free radicals.

Ozone oxidative preconditioning: a protection against cellular damage by free radicals.

Comentarios desactivados en Ozone oxidative preconditioning: a protection against cellular damage by free radicals.

O S León, S Menéndez, N Merino, R Castillo, S Sam, L Pérez, E Cruz, and V Bocci

Abstract

There is some anecdotal evidence that oxygen-ozone therapy may be beneficial in some human diseases. However so far only a few biochemical and pharmacodynamic mechanisms have been elucidated. On the basis of preliminary data we postulated that controlled ozone administration would promote an oxidative preconditioning preventing the hepatocellular damage mediated by free radicals. Six groups of rats were classified as follows: (1) negative control, using intraperitoneal sunflower oil; (2) positive control using carbon tetrachloride (CCl4) as an oxidative challenge; (3) oxygen-ozone, pretreatment via rectal insufflation (15 sessions) and after it, CCl4; (4) oxygen, as group 3 but using oxygen only; (5) control oxygen-ozone, as group 3, but without CCl4; group (6) control oxygen, as group 5, but using oxygen only. We have evaluated critical biochemical parameters such as levels of transaminase, cholinesterase, superoxide dismutase, catalase, phospholipase A, calcium dependent ATPase, reduced glutathione, glucose 6 phosphate dehydrogenase and lipid peroxidation. Interestingly, in spite of CCl4 administration, group 3 did not differ from group 1, while groups 2 and 4 showed significant differences from groups 1 and 3 and displayed hepatic damage. To our knowledge these are the first experimental results showing that repeated administration of ozone in atoxic doses is able to induce an adaptation to oxidative stress thus enabling the animals to maintain hepatocellular integrity after CCl4 poisoning.

Full Text

The Full Text of this article is available as a PDF (191K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Romero Valdés A, Menéndez Cepero S, Gómez Moraleda M, Ley Pozo J. La ozonoterapia en los estadíos avanzados de la aterosclerosis obliterante. Angiologia. 1993 Jul-Aug;45(4):146–148. [PubMed]
  • Hernández F, Menéndez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med. 1995 Jul;19(1):115–119. [PubMed]
  • Pryor WA. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic Biol Med. 1992;12(1):83–88. [PubMed]
  • Pryor WA, Church DF. Aldehydes, hydrogen peroxide, and organic radicals as mediators of ozone toxicity. Free Radic Biol Med. 1991;11(1):41–46. [PubMed]
  • Hotter G, Leon OS, Roselló-Catafau J, López-Boado MA, Parellada PP, Henriques RD, Fernández-Cruz L, Gelpí E. Tissular prostanoid release, phospholipase A2 activity, and lipid peroxidation in pancreas transplantation. Transplantation. 1991 May;51(5):987–990. [PubMed]
  • Makris PE, Tsakiris DA, Papadopoulos A, Ballas A. The ratio MDA/MDAa as a new index of platelet hyperactivity. Haemostasis. 1985;15(5):331–336. [PubMed]
  • HARVALD B, HANEL KH, SQUIRES R, TRAP-JENSEN J. ADENOSINE-TRIPHOSPHATASE DEFICIENCY IN PATIENTS WITH NON-SPHEROCYTIC HAEMOLYTIC ANAEMIA. Lancet. 1964 Jul 4;2(7349):18–19. [PubMed]
  • Ecobichon DJ. Glutathione depletion and resynthesis in laboratory animals. Drug Chem Toxicol. 1984;7(4):345–355. [PubMed]
  • Spector T. Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem. 1978 May;86(1):142–146. [PubMed]
  • DAVIES CE, STEINER RE. Calcified aortic valve; clinical and radiological features. Br Heart J. 1949 Apr;11(2):126–136. [PMC free article] [PubMed]
  • Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov;74(5):1124–1136. [PubMed]
  • Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents. 1996 Apr-Sep;10(2-3):31–53. [PubMed]
  • Brent JA, Rumack BH. Role of free radicals in toxic hepatic injury. I. Free radical biochemistry. J Toxicol Clin Toxicol. 1993;31(1):139–171. [PubMed]
  • Castillo M, Toledo-Pereyra LH, Shapiro E, Guerra E, Prough D, Frantzis P. Protective effect of allopurinol, catalase, or superoxide dismutase in the ischemic rat liver. Transplant Proc. 1990 Apr;22(2):490–491. [PubMed]
  • Oyanagui Y, Sato S. Superoxide dismutases and anti-oxidants protected mice from no-reflow and necrotic damage induced by ischemia. Free Radic Res Commun. 1993;18(3):147–157. [PubMed]
  • Chow CK, Tappel AL. Activities of pentose shunt and glycolytic enzymes in lungs of ozone-exposed rats. Arch Environ Health. 1973 Apr;26(4):205–208. [PubMed]
  • Weller BL, Crapo JD, Slot J, Posthuma G, Plopper CG, Pinkerton KE. Site- and cell-specific alteration of lung copper/zinc and manganese superoxide dismutases by chronic ozone exposure. Am J Respir Cell Mol Biol. 1997 Nov;17(5):552–560. [PubMed]
  • Sharma YK, Davis KR. The effects of ozone on antioxidant responses in plants. Free Radic Biol Med. 1997;23(3):480–488. [PubMed]
  • Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses. 1996 Feb;46(2):150–154. [PubMed]
  • Nakano H, Monden M, Umeshita K, Murata M, Miyoshi H, Kanai T, Gotoh M, Mori T. Protective effects of prostaglandin I2 analogues on superoxide-induced hepatocyte injury. Ann N Y Acad Sci. 1994 Jun 17;723:447–450. [PubMed]
  • Watanabe H, Onda M, Genga A, Asano G. [The role of Ca(2+)-ATPase and oxygen radical in reperfusion injury of rat liver]. Nihon Geka Gakkai Zasshi. 1993 Dec;94(12):1269–1276. [PubMed]
  • Ariki M, Shamoo AE. Oxidation of reactive sulfhydryl groups of sarcoplasmic reticulum ATPase. Biochim Biophys Acta. 1983 Sep 21;734(1):83–90. [PubMed]
  • Scherer NM, Deamer DW. Oxidative stress impairs the function of sarcoplasmic reticulum by oxidation of sulfhydryl groups in the Ca2+-ATPase. Arch Biochem Biophys. 1986 May 1;246(2):589–601. [PubMed]
  • Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995 Jan 16;358(1):1–3. [PubMed]
  • Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996;21(5):641–649. [PubMed]
  • Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 1996;36:83–106. [PubMed]

Articles from Mediators of Inflammation are provided here courtesy of Hindawi Publishing Corporation
Uruguay 1243 1º Dpto. 4º, C.A.B.A. Rep. Argentina. Martes y Jueves de 14 a 18hs. Tel/Fax (+54 11) 4815-1748 / 4812-2475 aaooac@aaooac.org.ar / asociacionmedicaozono@gmail.com
© 2016 Copyright Asociación Médica Argentina de Oxígeno Ozonoterapia

Back to Top